PIK3CD and breast cancer: As shown in Figure 8E–8F, the phosphorylation of PI3K and Akt were significantly blunted in UNC5B-knockdown breast cancer cells compared with breast cancer cells treated with NC-shRNA, suggesting the essential role of UNC5B in PI3K/Akt pathway activation.